NYSE · Medical - Healthcare Plans

UNH (UNH) Stock

$396.10 +1.72% NYSE: UNH Healthcare

Valuation

MetricValue
Price$396.10
Market Cap$359.72B
P/E Ratio25.79
P/B Ratio3.48
P/S Ratio0.81
EPS (TTM)$13.23
52-Week High$461.62
52-Week Low$255.97
Dividend Yield2.31%

Financials & Margins

MetricValue
ROE14.40%
ROA4.56%
ROCE8.12%
Gross Margin18.80%
Operating Margin4.19%
Net Margin3.14%
Debt/Equity0.70
Current Ratio0.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$287.6B$324.2B$371.6B$400.3B$447.6B
Operating Profit$24.0B$28.4B$32.4B$32.3B$19.0B
Net Profit$17.3B$20.1B$22.4B$14.4B$12.1B
EPS$18.08$21.18$23.86$15.51$13.23
Op Margin8.3%8.8%8.7%8.1%4.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$212.2B$245.7B$273.7B$298.3B$309.6B
Total Liabilities$135.7B$159.4B$174.8B$195.7B$207.9B
Cash$21.4B$23.4B$25.4B$25.3B$24.4B
Borrowings$46.0B$57.6B$67.4B$76.9B$78.4B

Latest News

UnitedHealth’s Stock Run Is Strong. Earnings Will Gauge Medicare Advantage Recovery. Barrons.com · Jul 15, 2026 Piper Sandler Raises Price Target on UnitedHealth Group to $475 From $420, Maintains Overweight Rating MT Newswires · Jul 15, 2026 Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries Barrons.com · Jul 15, 2026 ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues Zacks · Jul 15, 2026 Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$22.3B$26.2B$29.1B$24.2B$19.7B
Investing Cash Flow$-12.8B$-31.3B$-19.0B$-24.0B$-12.3B
Financing Cash Flow$-4.7B$-3.6B$-10.4B$-12.5B$-4.5B
Net Cash Flow$4.5B$2.0B$2.1B$-115.0M$2.8B
Free Cash Flow$19.9B$23.4B$25.7B$20.7B$16.1B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.78
EV / EBITDA15.87
FCF Yield6.49%
Quick Ratio1.24
Interest Coverage5.57
Return 1Y33.47%
Return 3Y-15.29%
Return 5Y11.79%

Ownership

Insiders Held0.24%
Institutions Held85.85%
Institutions Float Held86.05%
Institutional HolderSharesReport Date
Blackrock Inc.73,467,5312026-03-31
Vanguard Capital Management LLC58,870,7772026-03-31
State Street Corporation45,332,1862026-03-31
Capital World Investors27,783,4152026-03-31
Vanguard Portfolio Management LLC24,036,5042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABT $109.49 -0.79% 36.69 $189.46B 2.21%
AZN $161.96 -0.10% 24.78 $251.18B 1.28%
CI $279.86 +1.37% 11.58 $73.95B 2.22%
CVS $96.66 +2.93% 24.63 $123.33B 2.82%
ELV $401.92 +2.39% 17.89 $87.16B 1.71%

About UNH

UNH is led by CEO Stephen J. Hemsley, employs 400,000 people, headquartered in Eden Prairie, US, publicly traded since 1984.

UNH stock trades at $396.10 with a market capitalization of $359.72B. The stock is valued at a price-to-earnings (P/E) ratio of 25.79, price-to-book of 3.48, price-to-sales of 0.81. Over the past 52 weeks the stock has ranged between $255.97 and $461.62, and currently trades 14.2% below its 52-week high. It pays a dividend yielding 2.31%.

On profitability, UNH generates a return on equity (ROE) of 14.40%, above the typical market average, return on capital employed of 8.12%, an operating margin of 4.19%, a net profit margin of 3.14%.

In its most recent fiscal year, UNH reported annual revenue of $447.6B, net profit of $12.1B, revenue has compounded at 11.7% a year over the last five years, profit at -4.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.70, a current ratio of 0.80, total assets of $309.6B, $24.4B in cash and equivalents.

UNH has a beta of 0.63 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.59 +1.24% NVS Drug Manufacturers - General $161.48 +6.19% AZN Drug Manufacturers - General $161.96 -0.10% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.51 -2.53% NVO Biotechnology $45.17 -0.35% ABT Medical - Devices $109.49 -0.79% GILD Drug Manufacturers - General $148.94 +1.78% PFE Drug Manufacturers - General $28.49 +0.09%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides